The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones
Abstract
The effects of a variety of oxazolidinones, with different antibacterial potencies, including linezolid, on mitochondrial protein synthesis were determined in intact mitochondria isolated from rat heart and liver and rabbit heart and bone marrow. The results demonstrate that a general feature of the oxazolidinone class of antibiotics is the inhibition of mammalian mitochondrial protein synthesis. Inhibition was similar in mitochondria from all tissues studied. Further, oxazolidinones that were very potent as antibiotics were uniformly potent in inhibiting mitochondrial protein synthesis. These results were compared to the inhibitory profiles of other antibiotics that function by inhibiting bacterial protein synthesis. Of these, chloramphenicol and tetracycline were significant inhibitors of mammalian mitochondrial protein synthesis while the macrolides, lincosamides, and aminoglycosides were not. Development of future antibiotics from the oxazolidinone class will have to evaluate potential mitochondrial toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Genin, M. J., Allwine, D. A., Anderson, D. J., Barbachyn, M. R., Emmert, D. E., Garmon, S. A., Graber, D. R., Grega, K. C., Hester, J. B., Hutchinson, D. K., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990373e · Cited by 729
Brickner, S. J., Hutchinson, D. K., Barbachyn, M. R., Manninen, P. R., Ulanowicz, D. A., Garmon, S. A., Grega, K. C., Hendges, S. K., Toops, D. S., Ford, C. W., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509556 · Cited by 582
Oxazolidinone Structure–Activity Relationships Leading to Linezolid
Barbachyn, M. R., & Ford, C. W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200528 · Cited by 553
Hematologic Effects of Linezolid: Summary of Clinical Experience
Gerson, S. L., Kaplan, S. L., Bruss, J. B., Le, V., Arellano, F. M., Hafkin, B., & Kuter, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2723-2726.2002 · Cited by 443
Lin, A. H., Murray, R. W., Vidmar, T. J., & Marotti, K. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2127 · Cited by 261
Peripheral neuropathy associated with prolonged use of linezolid
Bressler, A. M., Zimmer, S. M., Gilmore, J. L., & Somani, J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01109-0 · Cited by 246
Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine Model
Cynamon, M. H., Klemens, S. P., Sharpe, C. A., & Chase, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1189 · Cited by 243
Comparative Safety of Tetracycline, Minocycline, and Doxycycline
Shapiro, L. E. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.10.1224 · Cited by 231
Structural basis for selectivity and toxicity of ribosomal antibiotics
Böttger, E. C., Springer, B., Prammananan, T., Kidan, Y. G., & Sander, P. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve062 · Cited by 174
Oxazolidinone Antibacterial Agents: A Critical Review
Hutchinson, D. K. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452195 · Cited by 151
Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics
Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C., Lund, E. T., Cavey, G. S., Mathews, W. R., Adams, L. D., Cecil, E. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302109200 · Cited by 139
Oxazolidinone Antibiotics Target the P Site onEscherichiacoliRibosomes
Aoki, H., Ke, L., Poppe, S. M., Poel, T. J., Weaver, E. A., Gadwood, R. C., Thomas, R. C., Shinabarger, D. L., & GANOZA, M. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1080-1085.2002 · Cited by 139
Hematologic Effects of Antimicrobials: Focus on the Oxazolidinone Linezolid
Kuter, D. J., & Tillotson, G. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.11.1010.34517 · Cited by 134
Chloramphenicol toxicity: 25 years of research.
Yunis, A. A. (1989) · PubMed · Cited by 104
Novel oxazolidinone–quinolone hybrid antimicrobials
Gordeev, M. F., Hackbarth, C. J., Barbachyn, M. R., Banitt, L. S., Gage, J. R., Luehr, G. W., Gómez, M., Trias, J., Morin, S., Zurenko, G. E., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.021 · Cited by 81
Ciprofloxacin does not inhibit mitochondrial functions but other antibiotics do
Riesbeck, K., Bredberg, A. C. A., & Forsgren, A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.167 · Cited by 66
The mitochondrial genetic system as a target for chemotherapy: Tetracyclines as cytostatics
Kroon, A. M., Dontje, B., Holtrop, M. E., & den Bogert, C. V. (1984) · Cancer Letters · doi:10.1016/s0304-3835(84)80023-3 · Cited by 64
BELOVA, E. (1996) · Experiment · doi:10.1163/2211730x96x00144 · Cited by 53
den Bogert, C. V., & Kroon, A. M. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90403-2 · Cited by 52
Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover rat
Turton, J. A., Andrews, C. M., Havard, A. C., Robinson, S., York, M. J., Williams, T. C., & Gibson, F. M. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00178-3 · Cited by 40
Naitoh, T., MISHIMA, M., Kawaguchi, S., MATSUI, K., ANDOH, T., Kagei, K., Kakiki, M., YUZURIHA, T., & HORIE, T. (1997) · Xenobiotica · doi:10.1080/004982597240028 · Cited by 5
Cited by
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.
Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K. R., MacLeod, G., Mis, M., Zimmermann, M., Fradet-Turcotte, A., Sun, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.015 · Cited by 1,571
Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., Sadler, J. J., Knepper-Adrian, V., Han, R., Qiao, L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.001 · Cited by 931
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Škrtić, M., Sriskanthadevan, S., Jhas, B., Gebbia, M., Wang, X., Wang, Z., Hurren, R., Jitkova, Y., Gronda, M., Maclean, N., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.015 · Cited by 678
Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D., & Will, Y. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm052 · Cited by 628
Bactericidal Antibiotics Induce Mitochondrial Dysfunction and Oxidative Damage in Mammalian Cells
Kalghatgi, S., Spina, C. S., Costello, J. C., Liesa, M., Morones-Ramirez, J. R., Slomovic, S., Molina, A., Shirihai, O. S., & Collins, J. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006055 · Cited by 563
Metadata
- Authors
- McKee, E. E., Ferguson, M., Bentley, A. T., & Marks, T. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-06
- Volume
- 50
- Issue
- 6
- Pages
- 2042-2049
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2108260765
- Cited by
- 270
- References
- 24
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.